Community pharmacists' challenges regarding adverse drug reaction reporting: a cross-sectional study. (3rd July 2022)

• Record Type: Journal Article
• Authors: Paut Kusturica, Milica; Tomas, Ana; Rašković, Aleksandar; Gigov, Slobodan; Crnobrnja, Veljko; Jevtić, Marija; Stilinović, Nebojša
• Is Part Of: Current medical research and opinion. Volume 38:Number 7(2022)
• Page Start: 1229
• Page End: 1236
• Publication Date: 2022-07-03
• Subjects: Pharmacovigilance -- adverse drug reaction reporting systems -- pharmacists -- knowledge -- Serbia; Clinical medicine -- Periodicals; Therapeutics -- Periodicals; 615.5
• DOI: 10.1080/03007995.2022.2070380
• Languages: English
• ISSNs: 0300-7995

Abstract

Abstract: Objective: The effectiveness of the national drug safety monitoring program directly depends on the active participation of healthcare professionals in reporting suspected adverse drug reactions (ADRs). The aim of the study was to explore community pharmacists' comprehension of pharmacovigilance, their perspectives toward reporting ADRs and investigate the current practice of ADR reporting among pharmacists in Serbia. Methods: This descriptive cross-sectional study was performed on a sample of pharmacists in Serbia between November 2019 and March 2020 using a pre-tested questionnaire distributed online. Eligible participants were community pharmacists in Serbia who were willing to participate in the study during the data collection period. Non-parametric statistical tests were performed in the analysis of knowledge, perspectives and ADR reporting. The validity and reliability of the survey were measured by exploratory factor analysis. Results: The median knowledge score was 6 out of 10 (interquartile range 5–7, range 2–10). No significant differences in the knowledge scores of pharmacists were found based on weekly working hours ( U = 24, 805, p = .374), working experience ( χ 2 = 4.011, DF = 2, p = .135), being a member of a professional organization ( U = 24, 312, p = .209), or highest level of pharmacy qualification obtained ( χ 2 = 3.233, DF = 3, p = .506). Only 28.8% of pharmacists reported ADR at least once a year, while the majority of them have never reported any ADRs. Conclusions: Despite the community pharmacists' positive attitude toward adverse drug reporting and their role in the process, they show limited knowledge regarding the issue and highly prevalent under-reporting of ADRs. Educational programs are necessary to increase ADRs reporting.